Home Healthcare Pharmaceuticals Psoriasis Treatment Market

Psoriasis Treatment Market Size, Share & Trends Analysis Report By Drug Class (Tumor Necrosis Factor Inhibitors, Interleukin Inhibitors, Vitamin D Analogues, Corticosteroids, Others), By Route of Administration (Parenteral, Oral, Topical), By Distribution Channel (Hospital Pharmacies, Drug Stores & Retail Pharmacies, Online Pharmacies) and By Region (North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2026-2034

Last Updated: May 19, 2026 | Author: Debashree B | Format:
Overview TOC Segmentation Methodology
Download Free Sample

Market Segmentation

  1. Psoriasis Treatment Market, By Drug Class 2022-2034 (USD MILLION/ Units)
    1. Tumor Necrosis Factor Inhibitors
    2. Interleukin Inhibitors
    3. Vitamin D Analogues
    4. Corticosteroids
    5. Others
  2. Psoriasis Treatment Market, By Route of Administration 2022-2034 (USD MILLION/ Units)
    1. Parenteral
    2. Oral
    3. Topical
  3. Psoriasis Treatment Market, By Distribution Channel 2022-2034 (USD MILLION/ Units)
    1. Hospital Pharmacies
    2. Drug Stores & Retail Pharmacies
    3. Online Pharmacies
  4. Regional Psoriasis Treatment Market
    1. North America
      1. North America Psoriasis Treatment Market By Drug Class 2022-2034 (USD MILLION/ Units)
        1. Tumor Necrosis Factor Inhibitors
        2. Interleukin Inhibitors
        3. Vitamin D Analogues
        4. Corticosteroids
        5. Others
      2. North America Psoriasis Treatment Market By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Parenteral
        2. Oral
        3. Topical
      3. North America Psoriasis Treatment Market By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Drug Stores & Retail Pharmacies
        3. Online Pharmacies
      4. U.S.
        1. Tumor Necrosis Factor Inhibitors
        2. Interleukin Inhibitors
        3. Vitamin D Analogues
        4. Corticosteroids
        5. Others
        6. Parenteral
        7. Oral
        8. Topical
        9. Hospital Pharmacies
        10. Drug Stores & Retail Pharmacies
        11. Online Pharmacies
      5. Canada
        1. Tumor Necrosis Factor Inhibitors
        2. Interleukin Inhibitors
        3. Vitamin D Analogues
        4. Corticosteroids
        5. Others
        6. Parenteral
        7. Oral
        8. Topical
        9. Hospital Pharmacies
        10. Drug Stores & Retail Pharmacies
        11. Online Pharmacies
    2. Europe
      1. Europe Psoriasis Treatment Market By Drug Class 2022-2034 (USD MILLION/ Units)
        1. Tumor Necrosis Factor Inhibitors
        2. Interleukin Inhibitors
        3. Vitamin D Analogues
        4. Corticosteroids
        5. Others
      2. Europe Psoriasis Treatment Market By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Parenteral
        2. Oral
        3. Topical
      3. Europe Psoriasis Treatment Market By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Drug Stores & Retail Pharmacies
        3. Online Pharmacies
      4. U.K.
        1. Tumor Necrosis Factor Inhibitors
        2. Interleukin Inhibitors
        3. Vitamin D Analogues
        4. Corticosteroids
        5. Others
        6. Parenteral
        7. Oral
        8. Topical
        9. Hospital Pharmacies
        10. Drug Stores & Retail Pharmacies
        11. Online Pharmacies
      5. Germany
        1. Tumor Necrosis Factor Inhibitors
        2. Interleukin Inhibitors
        3. Vitamin D Analogues
        4. Corticosteroids
        5. Others
        6. Parenteral
        7. Oral
        8. Topical
        9. Hospital Pharmacies
        10. Drug Stores & Retail Pharmacies
        11. Online Pharmacies
      6. France
        1. Tumor Necrosis Factor Inhibitors
        2. Interleukin Inhibitors
        3. Vitamin D Analogues
        4. Corticosteroids
        5. Others
        6. Parenteral
        7. Oral
        8. Topical
        9. Hospital Pharmacies
        10. Drug Stores & Retail Pharmacies
        11. Online Pharmacies
      7. Spain
        1. Tumor Necrosis Factor Inhibitors
        2. Interleukin Inhibitors
        3. Vitamin D Analogues
        4. Corticosteroids
        5. Others
        6. Parenteral
        7. Oral
        8. Topical
        9. Hospital Pharmacies
        10. Drug Stores & Retail Pharmacies
        11. Online Pharmacies
      8. Italy
        1. Tumor Necrosis Factor Inhibitors
        2. Interleukin Inhibitors
        3. Vitamin D Analogues
        4. Corticosteroids
        5. Others
        6. Parenteral
        7. Oral
        8. Topical
        9. Hospital Pharmacies
        10. Drug Stores & Retail Pharmacies
        11. Online Pharmacies
      9. Russia
        1. Tumor Necrosis Factor Inhibitors
        2. Interleukin Inhibitors
        3. Vitamin D Analogues
        4. Corticosteroids
        5. Others
        6. Parenteral
        7. Oral
        8. Topical
        9. Hospital Pharmacies
        10. Drug Stores & Retail Pharmacies
        11. Online Pharmacies
      10. Nordic
        1. Tumor Necrosis Factor Inhibitors
        2. Interleukin Inhibitors
        3. Vitamin D Analogues
        4. Corticosteroids
        5. Others
        6. Parenteral
        7. Oral
        8. Topical
        9. Hospital Pharmacies
        10. Drug Stores & Retail Pharmacies
        11. Online Pharmacies
      11. Benelux
        1. Tumor Necrosis Factor Inhibitors
        2. Interleukin Inhibitors
        3. Vitamin D Analogues
        4. Corticosteroids
        5. Others
        6. Parenteral
        7. Oral
        8. Topical
        9. Hospital Pharmacies
        10. Drug Stores & Retail Pharmacies
        11. Online Pharmacies
      12. Rest of Europe
        1. Tumor Necrosis Factor Inhibitors
        2. Interleukin Inhibitors
        3. Vitamin D Analogues
        4. Corticosteroids
        5. Others
        6. Parenteral
        7. Oral
        8. Topical
        9. Hospital Pharmacies
        10. Drug Stores & Retail Pharmacies
        11. Online Pharmacies
    3. APAC
      1. APAC Psoriasis Treatment Market By Drug Class 2022-2034 (USD MILLION/ Units)
        1. Tumor Necrosis Factor Inhibitors
        2. Interleukin Inhibitors
        3. Vitamin D Analogues
        4. Corticosteroids
        5. Others
      2. APAC Psoriasis Treatment Market By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Parenteral
        2. Oral
        3. Topical
      3. APAC Psoriasis Treatment Market By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Drug Stores & Retail Pharmacies
        3. Online Pharmacies
      4. China
        1. Tumor Necrosis Factor Inhibitors
        2. Interleukin Inhibitors
        3. Vitamin D Analogues
        4. Corticosteroids
        5. Others
        6. Parenteral
        7. Oral
        8. Topical
        9. Hospital Pharmacies
        10. Drug Stores & Retail Pharmacies
        11. Online Pharmacies
      5. Korea
        1. Tumor Necrosis Factor Inhibitors
        2. Interleukin Inhibitors
        3. Vitamin D Analogues
        4. Corticosteroids
        5. Others
        6. Parenteral
        7. Oral
        8. Topical
        9. Hospital Pharmacies
        10. Drug Stores & Retail Pharmacies
        11. Online Pharmacies
      6. Japan
        1. Tumor Necrosis Factor Inhibitors
        2. Interleukin Inhibitors
        3. Vitamin D Analogues
        4. Corticosteroids
        5. Others
        6. Parenteral
        7. Oral
        8. Topical
        9. Hospital Pharmacies
        10. Drug Stores & Retail Pharmacies
        11. Online Pharmacies
      7. India
        1. Tumor Necrosis Factor Inhibitors
        2. Interleukin Inhibitors
        3. Vitamin D Analogues
        4. Corticosteroids
        5. Others
        6. Parenteral
        7. Oral
        8. Topical
        9. Hospital Pharmacies
        10. Drug Stores & Retail Pharmacies
        11. Online Pharmacies
      8. Australia
        1. Tumor Necrosis Factor Inhibitors
        2. Interleukin Inhibitors
        3. Vitamin D Analogues
        4. Corticosteroids
        5. Others
        6. Parenteral
        7. Oral
        8. Topical
        9. Hospital Pharmacies
        10. Drug Stores & Retail Pharmacies
        11. Online Pharmacies
      9. Taiwan
        1. Tumor Necrosis Factor Inhibitors
        2. Interleukin Inhibitors
        3. Vitamin D Analogues
        4. Corticosteroids
        5. Others
        6. Parenteral
        7. Oral
        8. Topical
        9. Hospital Pharmacies
        10. Drug Stores & Retail Pharmacies
        11. Online Pharmacies
      10. South East Asia
        1. Tumor Necrosis Factor Inhibitors
        2. Interleukin Inhibitors
        3. Vitamin D Analogues
        4. Corticosteroids
        5. Others
        6. Parenteral
        7. Oral
        8. Topical
        9. Hospital Pharmacies
        10. Drug Stores & Retail Pharmacies
        11. Online Pharmacies
      11. Rest of Asia-Pacific
        1. Tumor Necrosis Factor Inhibitors
        2. Interleukin Inhibitors
        3. Vitamin D Analogues
        4. Corticosteroids
        5. Others
        6. Parenteral
        7. Oral
        8. Topical
        9. Hospital Pharmacies
        10. Drug Stores & Retail Pharmacies
        11. Online Pharmacies
    4. Middle East and Africa
      1. Middle East and Africa Psoriasis Treatment Market By Drug Class 2022-2034 (USD MILLION/ Units)
        1. Tumor Necrosis Factor Inhibitors
        2. Interleukin Inhibitors
        3. Vitamin D Analogues
        4. Corticosteroids
        5. Others
      2. Middle East and Africa Psoriasis Treatment Market By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Parenteral
        2. Oral
        3. Topical
      3. Middle East and Africa Psoriasis Treatment Market By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Drug Stores & Retail Pharmacies
        3. Online Pharmacies
      4. UAE
        1. Tumor Necrosis Factor Inhibitors
        2. Interleukin Inhibitors
        3. Vitamin D Analogues
        4. Corticosteroids
        5. Others
        6. Parenteral
        7. Oral
        8. Topical
        9. Hospital Pharmacies
        10. Drug Stores & Retail Pharmacies
        11. Online Pharmacies
      5. Turkey
        1. Tumor Necrosis Factor Inhibitors
        2. Interleukin Inhibitors
        3. Vitamin D Analogues
        4. Corticosteroids
        5. Others
        6. Parenteral
        7. Oral
        8. Topical
        9. Hospital Pharmacies
        10. Drug Stores & Retail Pharmacies
        11. Online Pharmacies
      6. Saudi Arabia
        1. Tumor Necrosis Factor Inhibitors
        2. Interleukin Inhibitors
        3. Vitamin D Analogues
        4. Corticosteroids
        5. Others
        6. Parenteral
        7. Oral
        8. Topical
        9. Hospital Pharmacies
        10. Drug Stores & Retail Pharmacies
        11. Online Pharmacies
      7. South Africa
        1. Tumor Necrosis Factor Inhibitors
        2. Interleukin Inhibitors
        3. Vitamin D Analogues
        4. Corticosteroids
        5. Others
        6. Parenteral
        7. Oral
        8. Topical
        9. Hospital Pharmacies
        10. Drug Stores & Retail Pharmacies
        11. Online Pharmacies
      8. Egypt
        1. Tumor Necrosis Factor Inhibitors
        2. Interleukin Inhibitors
        3. Vitamin D Analogues
        4. Corticosteroids
        5. Others
        6. Parenteral
        7. Oral
        8. Topical
        9. Hospital Pharmacies
        10. Drug Stores & Retail Pharmacies
        11. Online Pharmacies
      9. Nigeria
        1. Tumor Necrosis Factor Inhibitors
        2. Interleukin Inhibitors
        3. Vitamin D Analogues
        4. Corticosteroids
        5. Others
        6. Parenteral
        7. Oral
        8. Topical
        9. Hospital Pharmacies
        10. Drug Stores & Retail Pharmacies
        11. Online Pharmacies
      10. Rest of MEA
        1. Tumor Necrosis Factor Inhibitors
        2. Interleukin Inhibitors
        3. Vitamin D Analogues
        4. Corticosteroids
        5. Others
        6. Parenteral
        7. Oral
        8. Topical
        9. Hospital Pharmacies
        10. Drug Stores & Retail Pharmacies
        11. Online Pharmacies
    5. LATAM
      1. LATAM Psoriasis Treatment Market By Drug Class 2022-2034 (USD MILLION/ Units)
        1. Tumor Necrosis Factor Inhibitors
        2. Interleukin Inhibitors
        3. Vitamin D Analogues
        4. Corticosteroids
        5. Others
      2. LATAM Psoriasis Treatment Market By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Parenteral
        2. Oral
        3. Topical
      3. LATAM Psoriasis Treatment Market By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Drug Stores & Retail Pharmacies
        3. Online Pharmacies
      4. Brazil
        1. Tumor Necrosis Factor Inhibitors
        2. Interleukin Inhibitors
        3. Vitamin D Analogues
        4. Corticosteroids
        5. Others
        6. Parenteral
        7. Oral
        8. Topical
        9. Hospital Pharmacies
        10. Drug Stores & Retail Pharmacies
        11. Online Pharmacies
      5. Mexico
        1. Tumor Necrosis Factor Inhibitors
        2. Interleukin Inhibitors
        3. Vitamin D Analogues
        4. Corticosteroids
        5. Others
        6. Parenteral
        7. Oral
        8. Topical
        9. Hospital Pharmacies
        10. Drug Stores & Retail Pharmacies
        11. Online Pharmacies
      6. Argentina
        1. Tumor Necrosis Factor Inhibitors
        2. Interleukin Inhibitors
        3. Vitamin D Analogues
        4. Corticosteroids
        5. Others
        6. Parenteral
        7. Oral
        8. Topical
        9. Hospital Pharmacies
        10. Drug Stores & Retail Pharmacies
        11. Online Pharmacies
      7. Chile
        1. Tumor Necrosis Factor Inhibitors
        2. Interleukin Inhibitors
        3. Vitamin D Analogues
        4. Corticosteroids
        5. Others
        6. Parenteral
        7. Oral
        8. Topical
        9. Hospital Pharmacies
        10. Drug Stores & Retail Pharmacies
        11. Online Pharmacies
      8. Colombia
        1. Tumor Necrosis Factor Inhibitors
        2. Interleukin Inhibitors
        3. Vitamin D Analogues
        4. Corticosteroids
        5. Others
        6. Parenteral
        7. Oral
        8. Topical
        9. Hospital Pharmacies
        10. Drug Stores & Retail Pharmacies
        11. Online Pharmacies
      9. Rest of LATAM
        1. Tumor Necrosis Factor Inhibitors
        2. Interleukin Inhibitors
        3. Vitamin D Analogues
        4. Corticosteroids
        5. Others
        6. Parenteral
        7. Oral
        8. Topical
        9. Hospital Pharmacies
        10. Drug Stores & Retail Pharmacies
        11. Online Pharmacies
Report Details
−
200+ Trusted Partners
LG Electronics AMCAD Engineering KOBE STEEL LTD. Hindustan National Glass & Industries Limited Voith Group International Paper Hansol Paper Whirlpool Corporation Sony Samsung Electronics Qualcomm Google Fiserv Veto-Pharma Nippon Becton Dickinson Merck Argon Medical Devices Abbott Ajinomoto Denon Doosan Meiji Seika Kaisha Ltd LG Chemicals LCY chemical group Bayer Airrane BASF Toyota Industries Nissan Motors Neenah Mitsubishi Hyundai Motor Company Honda CRP Industries Inc pewag LGE Panasonic Lubrizol Corporation Leonardo Johnson & Johnson HB Fuller MITSUBISHI CHEMICAL Hyundai Mobis Amazon
Download Free Sample
Reach out to us
+1 646 905 0080 (U.S.)
+44 203 695 0070 (U.K.)
sales@straitsresearch.com

We are featured on:

Straits Research
Address:
105, Panchshil The Golden Bell,
Koregaon Park Annexe, Mundhwa,
Pune, Maharashtra 411036
Contact Us:
+1 646 905 0080 (U.S.)
+91 8087085354 (India)
+44 203 695 0070 (U.K.)

sales@straitsresearch.com

Quick Links
Help
Verified. Protected. Secure.
Duns
DMCA.com Protection Status
lets-encrypt
Secure Payments:
Secure Payments
Follow Us:
www.straitsresearch.com © Copyright . All rights Reserved.